type-2-diabetes

Documents about type-2-diabetes

• Quality Initiative to Improve Glucose Control in Type 2 Diabetic Patients#158136ClinicalTrials.gov
• A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus#127816ClinicalTrials.gov
• Research Study Comparing a New Medicine "Fast-acting Insulin Aspart" to Another Already Available Medicine "NovoRapid"/"NovoLog" in People With Type 2 Diabetes#127821ClinicalTrials.gov
• Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin#162419ClinicalTrials.gov
• Efficacy Of Autologous Bone Marrow Derived Stem Cell Transplantation In Patients With Type 2 Diabetes Mellitus-2#28585ClinicalTrials.gov
• Phase 2 Trial of Icovamenib in Participants With Type 2 Diabetes Mellitus Who Are Not Achieving Glycemic Targets While Using GLP-1-Based Therapy#158154ClinicalTrials.gov
• Regulatory T Cells in Type 1 Diabetes Patients Treated With IL-2#158139ClinicalTrials.gov
• Gut microbiome in type 2 diabetes: insights from metagenomics, multi-omics, and diet-microbe interactions#4547Europe PMC
• A Phase III Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes Who Are Not Well Controlled With Diet and Exercise#18547ClinicalTrials.gov
• Safety and Efficacy of Sitagliptin Compared With Glimepiride in Elderly Participants With Type 2 Diabetes Mellitus (MK-0431-251)#18825ClinicalTrials.gov
• VERIFY:A Study to Compare Combination Regimen With Vildagliptin & Metformin Versus Metformin in Treatment-naïve Patients With Type 2 Diabetes Mellitus#121293ClinicalTrials.gov
• Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin#121302ClinicalTrials.gov
• Effects of Sequential Treatment Based on Lina/MET After Short-term Intensive Insulin in Newly Diagnosed Type 2 Diabetes#123425ClinicalTrials.gov
• A Regulatory Requirement Non Interventional Study to Monitor Safety and Effectiveness of Trajenta Duo in Type 2 Diabetes Patients in Korea#126066ClinicalTrials.gov
• Association of AGTR1 and ACACB Gene Polymorphism and Diabetic Nephropathy in Type 2 Diabetes#127749ClinicalTrials.gov
• Blood-retinal Barrier Imaging and Neuropsychiatric Sequela in Type 2 Diabetes Mellitus#127769ClinicalTrials.gov
• Central Insulin Sensitivity in Individuals With Type 2 Diabetes (T2D) and at Risk for Developing T2D#146349ClinicalTrials.gov
• A Pragmatic Randomized Trial to Evaluate the Comparative Effectiveness Between Dapagliflozin and Standard of Care in Type 2 Diabetes Patients#146379ClinicalTrials.gov
• Effect of Acarbose and Mixture of Pioglitazone and Metformin in Patients With Type 2 Diabetes#146431ClinicalTrials.gov
• GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin#154863ClinicalTrials.gov
• A Phase III Study of BMS-512148 (Dapagliflozin) in Asian Patients With Type 2 Diabetes Who Are Not Well Controlled on Metformin Alone#154876ClinicalTrials.gov
• Randomized Controlled Trial of Digital Twin Precision Treatment: A Novel Whole Body Digital Twin Enabled Precision Treatment for Type 2 Diabetes#158188ClinicalTrials.gov
• Safety, Tolerability and Renal Effects of APX-115 in Subjects With Type 2 Diabetes and Nephropathy#160268ClinicalTrials.gov
• Efficacy and Safety of Empagliflozin (BI 10773) in Type 2 Diabetes Patients on a Background of Pioglitazone Alone or With Metformin#162417ClinicalTrials.gov
• The Effects of Glimepiride in Patients With Type 2 Diabetes and Chronic Heart Failure#172480ClinicalTrials.gov
• Differential Effects of Milk Proteins on Postprandial Lipemia in Response to a Fat-Rich Meal in Type 2 Diabetes#172488ClinicalTrials.gov
• A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)#172529ClinicalTrials.gov
• Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease#175037ClinicalTrials.gov
• A Study to Evaluate the Effect of ASP1941 in Combination With Metformin in Adult Patients With Type 2 Diabetes Mellitus#175096ClinicalTrials.gov
• Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy#180279ClinicalTrials.gov
• Linagliptin as Add on Therapy to Empagliflozin 10 mg or 25 mg With Background Metformin in Patient With Type 2 Diabetes#181731ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of MEDI0382 in the Treatment of Overweight and Obese Subjects With Type 2 Diabetes#184794ClinicalTrials.gov
• A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus#195506ClinicalTrials.gov
• Comparison of Glucovance to Insulin for Diabetes During Pregnancy#67832ClinicalTrials.gov
• Group Versus Traditional Prenatal Care for Diabetes#141114ClinicalTrials.gov
• Metformin for the Treatment of Diabetes in Pregnancy#154878ClinicalTrials.gov
• Mindfulness-Based Diabetes Education for Adults With Elevated Diabetes Distress#184789ClinicalTrials.gov
• Dexcom Continuous Glucose Monitoring in Long-term Care#121240ClinicalTrials.gov
• Efficacy of TAK-559 in Treating Subjects With Type 2 Diabetes Mellitus#126044ClinicalTrials.gov
• App-based Diabetes Management and Community-based Interventions#152609ClinicalTrials.gov
• A Real World Experience of Dapagliflozin in Type 2 Diabetes#158125ClinicalTrials.gov
• Efficacy of Alogliptin and Pioglitazone in Subjects With Type 2 Diabetes Mellitus#180338ClinicalTrials.gov
• Diabetes Discharge Transitional CGM Study (DDT-CGM)#184763ClinicalTrials.gov
• Phase 3 Alogliptin Pediatric Study#126088ClinicalTrials.gov
• Evaluation of Dapagliflozin Taken Twice-daily#136237ClinicalTrials.gov
• Tenelia Triple Combination Study#140971ClinicalTrials.gov
• Dose Response Study in Japanese Patients#158113ClinicalTrials.gov
• Peer Comparison-based Risk Communication#162394ClinicalTrials.gov
• Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)#160299ClinicalTrials.gov
• Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes#7133OpenAlex